http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016120787-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c530db308cc3f1a67c8a82a4c8de90 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-14 |
| filingDate | 2016-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40751f3c8a4ba875d3f69a4939547d4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc09870d71dc100258e25019894c8b88 |
| publicationDate | 2016-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2016120787-A1 |
| titleOfInvention | Oral n-acetylcysteine in the treatment of upper respiratory tract infections and symptoms |
| abstract | A method, treatment course, treatment regimen, and/or course of therapy, for: (1) treatment of an upper respiratory tract infection (URTI); (2) treatment of symptoms of an URTI; (3) reduction of cough associated with an URTI; (4) reduction of cough count associated with an URTI; (5) reduction of severity cough associated with an URTI; (6) reduction of cough duration associated with an URTI; (7) reduction of acute cough associated with an URTI; (8) reduction of duration of cough symptoms associated with an URTI; (9) reduction of the rate coughing associated with an URTI; (10) reduction of duration of an URTI; (11) treatment of common cold or symptoms thereof associated with productive cough; (12) treatment of viral URTI or symptoms thereof associated with productive cough; and/or (13) improvement in the quality of life of a subject having the URTI, in a subject in need thereof, comprising orally administering to the subject in need thereof a therapeutically effective amount of N-acetyl-L-cysteine (NAC), or a pharmaceutically acceptable salt, solvate, prodrug, or derivative thereof, and a pharmaceutically acceptable carrier; as well as a kit therefor. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3967300-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-202000021562-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021083867-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-201900019858-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021194890-A1 |
| priorityDate | 2015-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 99.